NCT02036281View on ClinicalTrials.gov

A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

September 28, 2016

Study Completion Date

September 28, 2016

Conditions
Terminally IllHistologically-confirmed Advanced CancerPain, Intractable
Interventions
DRUG

Substance P-Saporin

Trial Locations (2)

75390

UT Southwestern Medical Center Simmons Comprehensive Cancer Center, Dallas

92093-0698

University of California, San Diego Mores Cancer Center, La Jolla

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT02036281 - A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable Pain | Biotech Hunter | Biotech Hunter